Revive Therapeutics Ltd (RVVTF)

$0.02 0.00 (-0.52%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 42,100
Avg Vol 242,992
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 56%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which i...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888-901-0036
Fax: 905-248-3355
Address:
The Canadian Venture Building, 82 Richmond Street East, Toronto, Canada
Tbickle
Tbickle Jun. 29 at 12:04 AM
$RVVTF given the extended trial length the gag order and the sitting on results its likely theyll drop stellar data a stockpiling contract AND a manufacturing grant simultaneously
3 · Reply
sica1983
sica1983 Jun. 27 at 10:19 PM
$RVVTF So in Revive history there have essentially been three major periods of investor enthusiasm: • 2015: Bucillamine/gout clinical progress. • 2017: Cannabis and cannabinoid pipeline expansion during a hot cannabis market. • 2020-2021: Bucillamine Phase 3 COVID trial, when the stock again traded around $0.50-0.55. Each time stock surged to 0.40-0.50 cents area. Could the DRDC program become the biggest catalyst in the company’s history? Yes, if it ultimately results in validated efficacy and government procurement or broader adoption.
3 · Reply
sica1983
sica1983 Jun. 27 at 9:47 PM
$RVVTF Revive need money for day to day operations, so they need to raise money from time to time. The offering terms are pretty good in my opinion, the units were priced above where the common shares had recently been trading, which is generally a stronger signal and the investors are committing new capital, suggesting they see value at that price. The company is raising money to continue operations rather than issuing shares at an extremely distressed valuation. For existing shareholders, I’d characterize these terms as reasonably shareholder-friendly relative to what is often seen in small biotech companies.
1 · Reply
Tbickle
Tbickle Jun. 27 at 9:40 PM
$RVVTF a simultaneous data drop and a govt procurement and stockpile contract will easily rocket the stock price past the 5 cent warrant price
1 · Reply
Tbickle
Tbickle Jun. 27 at 9:34 PM
$RVVTF The drdc is in the drivers seat and Revive had no money for day to day operations. Strict bureaucratic rules restrict the government from subsidizing a company's day to day operations.
0 · Reply
SlickB
SlickB Jun. 27 at 5:18 PM
$RVVTF i should have known to sell @ above .3c. Been stuck here for so long.
2 · Reply
Tbickle
Tbickle Jun. 27 at 4:52 PM
$RVVTF when a military entity clears a drug for national defense, the data release is purposely delayed until procurement frameworks, logistics , and supply chain contracts are hammered out . If they release the data before securing a contract the company valuation spikes making procurement more expensive for the government. They keep the lid toghtly closed until they're ready to release the data and the procurement contract simultaneously
1 · Reply
Tbickle
Tbickle Jun. 27 at 4:44 PM
$RVVTF The DRDC is sitting on a completed trial and legally gagging the company which points heavily to strategic classification or procurement prep.
0 · Reply
Tbickle
Tbickle Jun. 27 at 5:04 AM
$RVVTF the DRDC "sitting on results" confirms that the trial is being treated with serious defense -grade administrative protocols
1 · Reply
Tbickle
Tbickle Jun. 27 at 1:03 AM
$RVVTF the animal trial rule can expedite approval and lead to immediate procurement and stockpiling requires 2 animal studies. The additional time could be because the CDRC decided to expand the trial to a second animal
0 · Reply
Latest News on RVVTF
No data available.
Tbickle
Tbickle Jun. 29 at 12:04 AM
$RVVTF given the extended trial length the gag order and the sitting on results its likely theyll drop stellar data a stockpiling contract AND a manufacturing grant simultaneously
3 · Reply
sica1983
sica1983 Jun. 27 at 10:19 PM
$RVVTF So in Revive history there have essentially been three major periods of investor enthusiasm: • 2015: Bucillamine/gout clinical progress. • 2017: Cannabis and cannabinoid pipeline expansion during a hot cannabis market. • 2020-2021: Bucillamine Phase 3 COVID trial, when the stock again traded around $0.50-0.55. Each time stock surged to 0.40-0.50 cents area. Could the DRDC program become the biggest catalyst in the company’s history? Yes, if it ultimately results in validated efficacy and government procurement or broader adoption.
3 · Reply
sica1983
sica1983 Jun. 27 at 9:47 PM
$RVVTF Revive need money for day to day operations, so they need to raise money from time to time. The offering terms are pretty good in my opinion, the units were priced above where the common shares had recently been trading, which is generally a stronger signal and the investors are committing new capital, suggesting they see value at that price. The company is raising money to continue operations rather than issuing shares at an extremely distressed valuation. For existing shareholders, I’d characterize these terms as reasonably shareholder-friendly relative to what is often seen in small biotech companies.
1 · Reply
Tbickle
Tbickle Jun. 27 at 9:40 PM
$RVVTF a simultaneous data drop and a govt procurement and stockpile contract will easily rocket the stock price past the 5 cent warrant price
1 · Reply
Tbickle
Tbickle Jun. 27 at 9:34 PM
$RVVTF The drdc is in the drivers seat and Revive had no money for day to day operations. Strict bureaucratic rules restrict the government from subsidizing a company's day to day operations.
0 · Reply
SlickB
SlickB Jun. 27 at 5:18 PM
$RVVTF i should have known to sell @ above .3c. Been stuck here for so long.
2 · Reply
Tbickle
Tbickle Jun. 27 at 4:52 PM
$RVVTF when a military entity clears a drug for national defense, the data release is purposely delayed until procurement frameworks, logistics , and supply chain contracts are hammered out . If they release the data before securing a contract the company valuation spikes making procurement more expensive for the government. They keep the lid toghtly closed until they're ready to release the data and the procurement contract simultaneously
1 · Reply
Tbickle
Tbickle Jun. 27 at 4:44 PM
$RVVTF The DRDC is sitting on a completed trial and legally gagging the company which points heavily to strategic classification or procurement prep.
0 · Reply
Tbickle
Tbickle Jun. 27 at 5:04 AM
$RVVTF the DRDC "sitting on results" confirms that the trial is being treated with serious defense -grade administrative protocols
1 · Reply
Tbickle
Tbickle Jun. 27 at 1:03 AM
$RVVTF the animal trial rule can expedite approval and lead to immediate procurement and stockpiling requires 2 animal studies. The additional time could be because the CDRC decided to expand the trial to a second animal
0 · Reply
Bull80
Bull80 Jun. 26 at 10:44 PM
$RVVTF Someone still giving them money is a good news. Why they have to raise and nothing from DRDC I am not sure. If DRDC was planning to acquire them why would they let them raise at these low prices. Not an expert will see. Only good I see someone must have seen something to give them $1M.
1 · Reply
Tbickle
Tbickle Jun. 26 at 9:05 PM
$RVVTF This financing structure is bullish for stock price
2 · Reply
Mitchz11
Mitchz11 Jun. 26 at 8:40 PM
$RVVTF good or bad? Or neither?
2 · Reply
Lessworkmorefunds
Lessworkmorefunds Jun. 26 at 8:23 PM
$RVVTF https://ceo.ca/@accesswire/revive-therapeutics-announces-proposed-private-placement
1 · Reply
BobWarner99
BobWarner99 Jun. 26 at 7:32 PM
$RVVTF If very positive News possibly drops after hours, it's going to be the longest weekend EVER. 🙂
2 · Reply
Tbickle
Tbickle Jun. 26 at 6:44 PM
$RVVTF Be greedy when others are fearful
0 · Reply
Mitchz11
Mitchz11 Jun. 26 at 5:11 PM
$RVVTF I have 164,407 shares. Wish I had more! What do you guys have?
5 · Reply
Bull80
Bull80 Jun. 26 at 4:28 PM
$RVVTF I think it just means that no one is selling their shares at the bid price. Technically, it makes sense — all the shareholders here are long-term investors who already purchased a good chunk and are waiting for the final payday
2 · Reply
BobWarner99
BobWarner99 Jun. 26 at 2:33 PM
$RVVTF I'm thinking next we see news next week???. Also financials appear to be due around June 30th 2026. Maybe MF is being advised to wait until audited financials are submitted before possibly releasing a significant positive update?? Maybe they aren't wanting news released now due to the Pink Limited Information tag? Who knows.....
0 · Reply
Barron401k
Barron401k Jun. 26 at 2:08 PM
$RVVTF what's your take on that 2.3 mil bid still hanging out at .0181?
1 · Reply
BeforeTheRobots
BeforeTheRobots Jun. 25 at 7:29 PM
$RVVTF we haven't quite hit $200 traded on the day. Not $200K. Two benjamins. Talk about stalemate...
0 · Reply
sica1983
sica1983 Jun. 25 at 5:02 PM
$RVVTF the large bid shows up again today little bit higher
0 · Reply